Skip to main content
. 2021 May 25;26(1):459–468. doi: 10.1007/s11325-021-02407-y

Table 2.

Comparison of sleep quality between the mastalgia and control groups

Control group NCBP group p
Median (min–max) PSQI ≤ 1
n (%)
PSQI > 1
n (%)
PSQI > 5
n (%)
Median (min–max) PSQI ≤ 1
n (%)
PSQI > 1 n (%) PSQI > 5
n (%)
P1 Subjective sleep quality 1 (0–3) 34 (77.2) 10 (22.8) 1 (0–3) 82 (70.7) 34 (29.3) 0.333
P2 Sleep latency 0 (0–2) 40 (90.9) 4 (9.1) 1 (0–3) 88 (75.9) 28 (24.1) 0.004
P3 Sleep duration 0 (0–2) 40 (90.9) 4 (9.1) 1 (0–3) 88 (75.9) 28 (24.1) 0.004
P4 Habitual sleep efficiency 1 (0–2) 37 (84.1) 7 (15.9) 1 (0–3) 95 (81.9) 21 (18.1) 0.221
P5 Sleep disturbance 1 (0–2) 29 (65.9) 15 (34.1) 1 (0–3) 65 (56) 51 (44) 0.274
P6 Use of sleep medication 0 (0–2) 43 (97.7) 1 (2.3) 0 (0–3) 107 (92.2) 9 (7.7) 0.058
P7 Daytime dysfunction 0 (0–2) 40 (90.9) 4 (9.1) 1 (0–2) 86 (74.2) 30 (25.9)  < 0.001
PSQI-global 3.5 (0–15) 17 (38.5) 6 (0–19) 69 (59.6) 0.007

Data given as median (min–max)

p < 0.05 was considered statistically significant. Statistically significant differences are indicated in bold

*Mann–Whitney U test